Canntab Therapeutics Ltd (PILL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 12-2017 | 05-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1 | 959 | 16 | 111 | 17 |
| Marketable Securities | N/A | N/A | 0 | 1,183 | N/A |
| Receivables | 6 | 41 | N/A | 48 | 5 |
| TOTAL | $10 | $999 | $17 | $1,343 | $24 |
| Non-Current Assets | |||||
| PPE Net | N/A | 99 | N/A | N/A | N/A |
| Investments And Advances | N/A | N/A | N/A | N/A | 258 |
| Intangibles | N/A | 39 | N/A | N/A | N/A |
| TOTAL | $0 | $138 | $0 | $0 | $258 |
| Total Assets | $10 | $1,137 | $17 | $1,343 | $282 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 120 | 91 | N/A | 150 | 27 |
| Accrued Expenses | 20 | 8 | N/A | 39 | 200 |
| Other current liabilities | N/A | N/A | N/A | 201 | N/A |
| TOTAL | $158 | $99 | $82 | $403 | $243 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $158 | $99 | $82 | $403 | $243 |
| Shareholders' Equity | |||||
| Common Shares | 3,040 | 1,400 | 2,940 | 3,591 | 0 |
| Retained earnings | -3,426 | -1,116 | -3,243 | -3,763 | -3,589 |
| Other shareholders' equity | 51 | 0 | 51 | 1,073 | 160 |
| TOTAL | $-148 | $1,039 | $-65 | $940 | $39 |
| Total Liabilities And Equity | $10 | $1,137 | $17 | $1,343 | $282 |